Cargando…
Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer
Chemotherapy is still the most fundamental treatment for advanced cancers so far. Previous studies have indicated that immune cell infiltration (ICI) index could serve as a biomarker to predict chemotherapy benefit in breast cancer and colorectal cancer. However, due to different responses of tumor...
Autores principales: | Bai, Yuquan, Li, Chuan, Xia, Liang, Gan, Fanyi, Zeng, Zhen, Zhang, Chuanfen, Deng, Yulan, Xu, Yuyang, Liu, Chengwu, Deng, Senyi, Liu, Lunxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771530/ https://www.ncbi.nlm.nih.gov/pubmed/35069897 http://dx.doi.org/10.7150/jca.65646 |
Ejemplares similares
-
Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer
por: Gan, Fanyi, et al.
Publicado: (2022) -
Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway
por: Cheng, Jiahan, et al.
Publicado: (2022) -
Circulating tumor DNA accurately predicts disease progression and genotype alterations in postoperative adjuvant EGFR-TKI resistance: a case report
por: Zeng, Zhen, et al.
Publicado: (2022) -
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
por: Bai, Yuquan, et al.
Publicado: (2022) -
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma
por: Leng, Xuefeng, et al.
Publicado: (2021)